Administration of Dutasteride in Animal Models of Retinitis Pigmentosa

    December 2022 in “ Acta Ophthalmologica
    María Miranda Sanz, Antolin Cantó, Teresa Olivar, Rosa López-Pedrajas, Javier Martínez-González, Vicente Hernández-Rabaza, Inmaculada Almansa
    New to Dutasteride? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study, dutasteride treatment in retinitis pigmentosa mice increased photoreceptor survival and reduced glial activation, suggesting it may offer a neuroprotective effect.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigated the effects of dutasteride (DUT), a 5α-reductase inhibitor used for androgenic alopecia, on retinitis pigmentosa (RP) in mice. The researchers hypothesized that DUT could increase progesterone levels in the retina, providing neuroprotection. The mice were treated with DUT and euthanized on day 21 for analysis. The results showed that DUT increased photoreceptor survival, normalized the number and migration of iba-1 positive cells, decreased glial fibrillar acid protein (GFAP) expression, and reduced neuronal nitric oxide synthase (nNOS) expression. The study concluded that DUT could potentially improve cell survival and ameliorate retinal micro and macroglial activation, as well as alterations in nNOS in RP.
    Discuss this study in the Community →